Viewpoint
18 Klueber R, O’Keefe Robert M. Defining and assessing requisite supply chain visibility in regulated industries. Journal of Enterprise Information Management 2013;26:295–315. 19 Resilience360. Impact of COVID-19 outbreak on border closures and global Freight movement . Special Report: DHL, 2020. 20 Foster P, Neville S. How poor planning left the UK without enough PPE. The Financial Times 2020. 21 Gustafsson L. COVID-19 highlights problems with our generic supply chain . To the Point: Quick Takes on Health Care Policy and Practice: The Commonwealth Fund, 2020. 22 Robinson F. Self-Protection: how NHS doctors are sourcing their own PPE. BMJ 2020;369:m1834. 23 Dyer C. Covid-19: doctors make Bid for public inquiry into lack of PPE for frontline workers. BMJ 2020;369:m1905. 24 Newton PN, Bond KC, Adeyeye M, et al . COVID-19 and risks to the supply and quality of tests, drugs, and vaccines. The Lancet Global Health 2020 [published Online First: April 9] 25 OECD. Stocktaking report on immediate public procurement and infrastructure responses to COVID-19. OECD policy responses to coronavirus (COVID-19 . Paris: Organisation for Economic Cooperation and Development, 2020. 26 Gondi S, Beckman AL, Deveau N, et al . Personal protective equipment needs in the USA during the COVID-19 pandemic. Lancet 2020;395:e90–1. 27 Public Accounts Committee UK. Whole of government response to COVID-19. thirteenth report of session 2019–21 UK: house of commons , 2020. 28 National Academies US. Medical product shortages during disasters: opportunities to predict, prevent, and respond: proceedings of a workshop in brief . Washington, DC: National Academies of Sciences, Engineering, and Medicine, 2018. 29 Sinha MS, Bourgeois FT, Sorger PK. Personal protective equipment for COVID-19: distributed fabrication and additive manufacturing. Am J Public Health 2020;110:e1–3. 30 Usher AD. COVID-19 vaccines for all? The Lancet 2020;395:1822–3. 31 European Commission. Pharmaceutical Strategy - Timely patient access to affordable medicines . 4. Roadmap. Brussels, 2020. 32 Javorcik B. Global supply chains will not be the same in the post-COVID-19 world. In: Baldwin R, Evenett S, eds. COVID-19 and Trade Policy: Why Turning Inward Won’t Work . London, UK: VoxEU.o rg eBook, CEPR Press, 2020: 111–6.
33 Fox ER, McLaughlin MM. ASHP guidelines on managing drug product shortages. American Journal of Health-System Pharmacy 2018;75:1742–50. 34 Dixon-Woods M, Pronovost PJ. Patient safety and the problem of many hands. BMJ Quality & Safety 2016;25:485–8. 35 MacKenzie CA, Barker K, Santos JR. Modeling a severe supply chain disruption and post-disaster decision making with application to the Japanese earthquake and tsunami. IIE Transactions 2014;46:1243–60. 36 Oahn Ha K, Raghu A. Now the World’s Hospitals Are Running out of Vital Rubber Gloves . Time: Bloomberg, 2020. 37 Chopra S, Sodhi M. Managing risk to avoid supply-chain breakdown. MIT Sloan management review 2004;46:53–61. 38 Jensen V, Rappaport BA. The reality of drug shortages— the case of the injectable agent propofol. N Engl J Med 2010;363:806–7. 39 Hinman AR, Orenstein WA, Santoli JM, et al . Vaccine shortages: history, impact, and prospects for the future. Annual Review of Public Health 2006;27:235–59. 40 Anupindi R. Case study: Boeing’s Dreamliner. Financial Times 2011 October 10 . 41 OECD. The face mask global value chain in the COVID-19 outbreak: evidence and policy lessons. OECD policy responses to coronavirus (COVID-19 . Paris: Organisation for Economic Cooperation and Development, 2020. 42 Orton-Jones C. 10 supply chain disasters . Raconteur, 2017. 43 Gossner CM-E, Schlundt J, Ben Embarek P, et al . The melamine incident: implications for international food and feed safety. Environmental health perspectives 2009;117:1803–8. 44 Tanne JH. Four deaths and 350 adverse events lead to US recall of heparin. BMJ (Clinical research ed) 2008;336:412–3. 45 Snodin DJ, Elder DP. Short commentary on NDMA (N- nitrosodimethylamine) contamination of valsartan products. Regulatory Toxicology and Pharmacology 2019;103:325–9 https://doi.org/ 46 Stone J, Rahimifard S. Resilience in agri-food supply chains: a critical analysis of the literature and synthesis of a novel framework. Supply Chain Management: An International Journal 2018;23:207–38. 47 Knight BP. The temptation of a single vendor device contract. EP Lab Digest 2011;11. 48 Modisakeng C, Matlala M, Godman B, et al . Medicine shortages and challenges with the procurement process among public sector hospitals in South Africa; findings and implications. BMC Health Serv Res 2020;20:234–34.
335
Miller FA, et al . BMJ Qual Saf 2021; 30 :331–335. doi:10.1136/bmjqs-2020-012133
Powered by FlippingBook